Total Payments
$11,624
2024 Payments
$253.15
Companies
42
Transactions
651
Medicare Patients
878
Medicare Billing
$78,620
Payment Breakdown by Category
Food & Beverage$11,497 (98.9%)
Education$126.63 (1.1%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $11,497 | 646 | 98.9% |
| Education | $126.63 | 5 | 1.1% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Novo Nordisk Inc | $1,542 | 74 | $0 (2024) |
| PFIZER INC. | $1,439 | 66 | $0 (2024) |
| AbbVie Inc. | $1,403 | 78 | $0 (2023) |
| AstraZeneca Pharmaceuticals LP | $916.75 | 51 | $0 (2020) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $799.77 | 40 | $0 (2022) |
| Novartis Pharmaceuticals Corporation | $493.35 | 25 | $0 (2023) |
| GlaxoSmithKline, LLC. | $492.51 | 29 | $0 (2023) |
| Takeda Pharmaceuticals U.S.A., Inc. | $455.08 | 33 | $0 (2022) |
| Allergan Inc. | $433.15 | 35 | $0 (2019) |
| Amgen Inc. | $428.75 | 24 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $253.15 | 11 | Novo Nordisk Inc ($152.64) |
| 2023 | $920.50 | 41 | PFIZER INC. ($303.31) |
| 2022 | $1,085 | 51 | PFIZER INC. ($260.52) |
| 2021 | $1,652 | 84 | PFIZER INC. ($289.77) |
| 2020 | $913.61 | 47 | AbbVie Inc. ($205.12) |
| 2019 | $1,577 | 79 | AbbVie, Inc. ($260.22) |
| 2018 | $2,391 | 158 | AstraZeneca Pharmaceuticals LP ($374.05) |
| 2017 | $2,832 | 180 | AstraZeneca Pharmaceuticals LP ($431.54) |
All Payment Transactions
651 individual payment records from CMS Open Payments — Page 1 of 27
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 09/25/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $24.76 | General |
| Category: Obesity | ||||||
| 06/24/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $22.07 | General |
| Category: Obesity | ||||||
| 06/18/2024 | Novo Nordisk Inc | — | Food and Beverage | In-kind items and services | $21.24 | General |
| 06/11/2024 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $22.98 | General |
| Category: Oncology | ||||||
| 04/24/2024 | PFIZER INC. | ELIQUIS (Drug), PAXLOVID, NURTEC ODT | Food and Beverage | In-kind items and services | $27.87 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 04/08/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $22.07 | General |
| Category: Obesity | ||||||
| 03/22/2024 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $24.25 | General |
| Category: Diabetes | ||||||
| 02/26/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $17.85 | General |
| Category: Obesity | ||||||
| 02/22/2024 | PFIZER INC. | ELIQUIS (Drug), PAXLOVID, NURTEC ODT | Food and Beverage | In-kind items and services | $25.63 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 02/01/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $20.40 | General |
| Category: Obesity | ||||||
| 01/03/2024 | PFIZER INC. | ELIQUIS (Drug), PAXLOVID, NURTEC ODT | Food and Beverage | In-kind items and services | $24.03 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 11/29/2023 | PFIZER INC. | ELIQUIS (Drug), PAXLOVID, NURTEC ODT | Food and Beverage | In-kind items and services | $28.16 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 11/16/2023 | AbbVie Inc. | SYNTHROID (Drug) | Food and Beverage | In-kind items and services | $26.63 | General |
| Category: IMMUNOLOGY | ||||||
| 11/08/2023 | PFIZER INC. | COMIRNATY (Biological), ABRYSVO | Food and Beverage | In-kind items and services | $24.16 | General |
| Category: VACCINES | ||||||
| 10/31/2023 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $22.91 | General |
| Category: Oncology | ||||||
| 10/10/2023 | PFIZER INC. | ELIQUIS (Drug) | Food and Beverage | In-kind items and services | $32.92 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 10/09/2023 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $2.46 | General |
| Category: Obesity | ||||||
| 09/13/2023 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug), TRULANCE | Food and Beverage | In-kind items and services | $12.92 | General |
| Category: Gastroenterology | ||||||
| 09/12/2023 | SANOFI PASTEUR INC. | FLUZONE QUADRIVALENT NORTHERN HEMISPHERE (Biological), FLUZONE QUADRIVALENT NORTHERN HEMISPHERE, FLUZONE HIGH-DOSE | Food and Beverage | In-kind items and services | $18.58 | General |
| Category: Vaccines | ||||||
| 08/24/2023 | Medicure Pharma Inc. | Zypitamag (Drug) | Food and Beverage | Cash or cash equivalent | $14.26 | General |
| Category: HMG-CoA reductase inhibitor | ||||||
| 08/21/2023 | Amgen Inc. | EVENITY (Biological), Prolia | Food and Beverage | In-kind items and services | $28.49 | General |
| Category: Bone Health | ||||||
| 08/17/2023 | PFIZER INC. | ELIQUIS (Drug) | Food and Beverage | In-kind items and services | $30.56 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 08/15/2023 | GlaxoSmithKline, LLC. | AREXVY (Drug), SHINGRIX | Food and Beverage | In-kind items and services | $22.07 | General |
| Category: RESPIRATORY | ||||||
| 08/09/2023 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug), TRULANCE | Food and Beverage | In-kind items and services | $16.59 | General |
| Category: Gastroenterology | ||||||
| 08/03/2023 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $22.24 | General |
| Category: Diabetes | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 9 | 387 | 633 | $92,164 | $38,614 |
| 2022 | 7 | 181 | 226 | $36,936 | $16,768 |
| 2021 | 6 | 128 | 171 | $21,873 | $10,708 |
| 2020 | 8 | 182 | 229 | $30,596 | $12,529 |
Total Patients
878
Total Services
1,259
Medicare Billing
$78,620
Procedure Codes
30
All Medicare Procedures & Services
30 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 43 | 166 | $33,200 | $15,381 | 46.3% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2023 | 70 | 70 | $28,000 | $10,613 | 37.9% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 47 | 66 | $18,150 | $8,616 | 47.5% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 89 | 92 | $5,270 | $1,107 | 21.0% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 18 | 86 | $4,090 | $921.01 | 22.5% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 86 | 101 | $1,515 | $848.40 | 56.0% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2023 | 11 | 11 | $1,100 | $787.84 | 71.6% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 12 | 12 | $420.00 | $317.46 | 75.6% |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | Office | 2023 | 11 | 29 | $419.00 | $22.00 | 5.3% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2022 | 39 | 39 | $14,750 | $7,029 | 47.7% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 24 | 57 | $11,400 | $4,232 | 37.1% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 21 | 23 | $6,325 | $3,304 | 52.2% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2022 | 19 | 19 | $1,466 | $1,250 | 85.2% |
| G0008 | Administration of influenza virus vaccine | Office | 2022 | 19 | 19 | $475.00 | $465.50 | 98.0% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2022 | 31 | 33 | $1,980 | $381.84 | 19.3% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2022 | 28 | 36 | $540.00 | $106.74 | 19.8% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 20 | 56 | $11,200 | $4,853 | 43.3% |
| 99205 | New patient outpatient visit, total time 60-74 minutes | Office | 2021 | 19 | 19 | $7,125 | $3,700 | 51.9% |
| 90662 | Vaccine for influenza for injection into muscle, split virus, preservation free | Office | 2021 | 23 | 23 | $1,403 | $1,403 | 100.0% |
| G0008 | Administration of influenza virus vaccine | Office | 2021 | 24 | 24 | $600.00 | $430.56 | 71.8% |
| 93000 | Routine ekg using at least 12 leads including interpretation and report | Office | 2021 | 18 | 18 | $1,080 | $235.26 | 21.8% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2021 | 24 | 31 | $465.00 | $86.80 | 18.7% |
| 99205 | New patient office or other outpatient visit, typically 60 minutes | Office | 2020 | 29 | 29 | $10,875 | $4,651 | 42.8% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 17 | 42 | $8,400 | $3,137 | 37.3% |
| 99215 | Established patient office or other outpatient, visit typically 40 minutes | Office | 2020 | 19 | 24 | $6,600 | $2,403 | 36.4% |
About Dr. Gilberto Zavala, MD
Dr. Gilberto Zavala, MD is a Internal Medicine healthcare provider based in Chicago, Illinois. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/12/2006. The National Provider Identifier (NPI) number assigned to this provider is 1699700872.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Gilberto Zavala, MD has received a total of $11,624 in payments from pharmaceutical and medical device companies, with $253.15 received in 2024. These payments were reported across 651 transactions from 42 companies. The most common payment nature is "Food and Beverage" ($11,497).
As a Medicare-enrolled provider, Zavala has provided services to 878 Medicare beneficiaries, totaling 1,259 services with total Medicare billing of $78,620. Data is available for 4 years (2020–2023), covering 30 distinct procedure/service records.
Ad
Practice Information
- Specialty Internal Medicine
- Location Chicago, IL
- Active Since 07/12/2006
- Last Updated 05/08/2020
- Taxonomy Code 207R00000X
- Entity Type Individual
- NPI Number 1699700872
Products in Payments
- ELIQUIS (Drug) $982.97
- FARXIGA (Drug) $500.25
- ENTRESTO (Drug) $493.35
- Livalo (Drug) $408.63
- LINZESS (Drug) $392.41
- JARDIANCE (Drug) $375.97
- Ozempic (Drug) $326.80
- Victoza (Drug) $315.23
- EVENITY (Biological) $307.02
- SYMBICORT (Drug) $279.98
- Synthroid (Drug) $260.58
- CHANTIX (Drug) $240.47
- STIOLTO RESPIMAT (Drug) $226.69
- TRINTELLIX (Drug) $215.42
- Rybelsus (Drug) $204.59
- Trintellix (Drug) $203.61
- Saxenda (Drug) $203.18
- Wegovy (Drug) $201.84
- JANUVIA (Drug) $201.78
- XIFAXAN (Drug) $193.88
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Chicago
Dr. Myles Wolf, Md, MD
Internal Medicine — Payments: $1.8M
Internal Medicine $1.8M
Dr. Merle Diamond, Md, MD
Internal Medicine — Payments: $1.4M
Internal Medicine $1.4M
Dr. Elizabeth Kiracofe, M.d, M.D
Internal Medicine — Payments: $1.2M
Internal Medicine $1.2M
Robert Kushner, Md, MD
Internal Medicine — Payments: $549,886
Internal Medicine $549,886
Dr. Adam Stein, M.d, M.D
Internal Medicine — Payments: $503,325
Internal Medicine $503,325
Devalingam Mahalingam, M.d, M.D
Internal Medicine — Payments: $501,247
Internal Medicine $501,247